Bio systems
thinker

Ipshita has over 15 years’ experience in academia, private and public sectors in bio sciences, technology and financial services.

She had completed a BTech in Biotechnology at the University of Auckland and a PhD in Chemical Engineering and Biotechnology at the University of Cambridge. She co-founded the Global Biotech Revolution in 2012, led the first GapSummit and growth of GBR activities including events in Singapore and the US till 2017 and is currently still a Steering Committee member. She also worked in a synthetic biology and chemistry biotech Nanna Therapeutics as CBO, which was eventually acquired by Astellas Pharmaceuticals for its rare disease pre-clinical assets. She then worked at McKinsey and Company in the India and US offices primarily in the technology, public sector and pharma practice areas (including as Chief of Staff to a $60Bn merger between Takeda and Shire). She has been an advocate for gender lens impact investing and women’s health through Global Bio Fund (invested in Baymatob in 2022 a med tech in maternal health) and the Xcellerator community.

She has provided advice to a portfolio of innovative and systemic investment projects in NZ through BioPacific Partners, Impact Lab, Malaghan Institute of Medical Research, MBIE funded RNA Development Platform and Advanced Technologies team. She is also passionate about bio systems thinking-philosophy and nature poetry.

She has received multiple professional awards including thrice being listed in the UK 50 Movers and Shakers in Bio Business, selected to be a Leader of Tomorrow at the 43 rd St Gallen Symposium and twice nominated as a Young Global Leader to the World Economic Forum (2024-25).